CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled
Drug / intervention
Medtronic Interstim II Model 3058 Neurostimulatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04473469
NCT04473469N/ACompleted
CompareCT.gov

Previously Implanted Pudendal Nerve Stimulation

University of Michigan·interventional·Posted Jul 16, 2020·Updated Jun 3, 2024

In Brief

A clinical study evaluating Medtronic Interstim II Model 3058 Neurostimulator for Urinary Retention and Underactive Bladder. Completed, enrolled 5 participants across 1 site.

Detailed Summary

This study seeks to examine the response of the bladder to different pudendal nerve stimulation frequencies, by studying patients who have been previously-implanted with pudendal nerve neurostimulators.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUrinary Retention, Underactive Bladder
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJul 16, 2020
Enrollment StartJan 19, 2021
Primary CompletionMay 2, 2023
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 6.0 years ago

Interventions

Medtronic Interstim II Model 3058 Neurostimulatordevice

Patients will undergo stimulation of the pudendal nerve. All stimulation parameters used will be within the normal hard-coded limits of the implantable pulse generator (IPG).